Interdepartmental Division of Critical Care Medicine, Toronto General Hospital, and.
Département de Médecine, Hôpital du Sacré-Coeur de Montréal, and.
Am J Respir Crit Care Med. 2020 Jun 15;201(12):1525-1535. doi: 10.1164/rccm.202001-0023OC.
: Large decreases in Pa that occur when initiating extracorporeal membrane oxygenation (ECMO) in patients with respiratory failure may cause cerebral vasoconstriction and compromise brain tissue perfusion.: To determine if the magnitude of Pa correction upon ECMO initiation is associated with an increased incidence of neurological complications in patients with respiratory failure.: We conducted a multicenter, international, retrospective cohort study using the Extracorporeal Life Support Organization Registry, including adults with respiratory failure receiving ECMO via any mode between 2012 and 2017. The relative change in Pa in the first 24 hours was calculated as (24-h post-ECMO Pa - pre-ECMO Pa)/pre-ECMO Pa. The primary outcome was the occurrence of neurological complications, defined as seizures, ischemic stroke, intracranial hemorrhage, or brain death.: We included 11,972 patients, 88% of whom were supported with venovenous ECMO. The median relative change in Pa was -31% (interquartile range, -46% to -12%). Neurological complications were uncommon overall (6.9%), with a low incidence of seizures (1.1%), ischemic stroke (1.9%), intracranial hemorrhage (3.5%), and brain death (1.6%). Patients with a large relative decrease in Pa (>50%) had an increased incidence of neurological complications compared with those with a smaller decrease (9.8% vs. 6.4%; < 0.001). A large relative decrease in Pa was independently associated with neurological complications after controlling for previously described risk factors (odds ratio, 1.7; 95% confidence interval, 1.3 to 2.3; < 0.001).: In patients receiving ECMO for respiratory failure, a large relative decrease in Pa in the first 24 hours after ECMO initiation is independently associated with an increased incidence of neurological complications.
在呼吸衰竭患者开始体外膜肺氧合(ECMO)时,动脉压大幅下降可能导致脑血管收缩,并影响脑组织灌注。
确定 ECMO 启动时动脉压校正幅度与呼吸衰竭患者神经并发症发生率增加是否相关。
我们利用体外生命支持组织登记处进行了一项多中心、国际性、回顾性队列研究,纳入了 2012 年至 2017 年期间通过任何模式接受 ECMO 治疗的呼吸衰竭成人患者。在最初 24 小时内,动脉压的相对变化通过(ECMO 后 24 小时 Pa-ECMO 前 Pa)/ECMO 前 Pa 计算得出。主要结局是发生神经系统并发症,包括癫痫发作、缺血性中风、颅内出血或脑死亡。
共纳入 11972 例患者,其中 88%接受静脉-静脉 ECMO 支持。动脉压的相对变化中位数为-31%(四分位距,-46%至-12%)。总体而言,神经系统并发症并不常见(6.9%),癫痫发作发生率较低(1.1%)、缺血性中风(1.9%)、颅内出血(3.5%)和脑死亡(1.6%)。与动脉压下降幅度较小的患者相比,动脉压大幅下降(>50%)的患者发生神经系统并发症的发生率更高(9.8% vs. 6.4%;<0.001)。在控制了先前描述的危险因素后,动脉压的大幅下降与神经系统并发症独立相关(比值比,1.7;95%置信区间,1.3 至 2.3;<0.001)。
在接受 ECMO 治疗呼吸衰竭的患者中,ECMO 启动后最初 24 小时内动脉压的相对大幅下降与神经并发症发生率增加独立相关。